Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-25 @ 4:42 AM
NCT ID:
NCT00820118
Eligibility Criteria:
Inclusion Criteria:
* adult confirmed HIV-1 infection
* no previous treatment with antiretroviral drugs or interleukin-2
* CD4 count ≥ 500/mm3
* no active opportunistic infection
* written informed consent
Exclusion Criteria:
* non barrier contraception in women of child bearing potential, pregnant or breastfeeding woman, pregnancy project within the next 2 years
* HIV-2 infection (with or without HIV-1), recent HIV primary infection, resistance to trial drugs at study entry, Ag HBs+, HCV requiring specific therapy
* previous history of cerebrovascular accident or coronary heart disease, splenectomy
* previous CD4 count \< 400/mm3
* CD4 percentage \< 15%
* hemoglobin \< 8 g/dl, neutrophils \< 750/mm3, platelets \< 100.000/mm3, creatinine clearance \< 50 ml/mn, AST or ALT or total bilirubin \> 3 ULN
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00820118
Study Brief:
Protocol Section:
NCT00820118